VONTOBEL FINANCIAL PRODUCTS GMBH | Market Closed - Borsa Italiana 11:44:59 2024-06-20 EDT | ||
| 99.75 EUR | +0.15% |
|
| Current month | -1.09% | ||
| 1 month | -1.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 99.75 | +0.15% |
| 24-06-19 | 99.6 | +1.32% |
| 24-06-18 | 98.3 | -0.56% |
| 24-06-17 | 98.85 | -1.54% |
| 24-06-14 | 100.4 | +0.20% |
Real-time Borsa Italiana
Last update June 20, 2024 at 11:44 am
More quotesStatic data
| Product type | Certificati Azionari e Obbl.ri |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| F43045 | |
| ISIN | DE000VM7TJ72 |
| Date issued | 2024-01-10 |
| Maturity | 2026-01-08 (567 Days) |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 104.3 € |
|---|---|
| Lowest since issue | 95.9 € |
| Spread | 1.1 € |
| Spread % | 1.10% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.81
USD
Average target price
53.19
USD
Spread / Average Target
+30.35%
- Stock Market
- Certificates
- F43045 Certificat
